SEC Form 4 · accession 0001600132-16-000095
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Naseem Amin
Director
Period of report
Jun 17, 2016
Accepted (ET)
Jun 21, 2016 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.94 | Jun 17, 2016 | A | 10,000 | A | — | Jun 16, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option was granted on June 17, 2016. This option vests in three equal annual installments over a three-year period from the date of grant.